As COVID-19 Vaccine Nears FDA Approval, Distribution, Sen. Shaheen Receives Virtual Briefing on Lonza's Vaccine Manufacturing Efforts
December 05, 2020
December 05, 2020
PORTSMOUTH, New Hampshire, Dec. 5 -- Sen. Jeanne Shaheen, D-New Hampshire, issued the following news release on Dec. 4:
Today, U.S. Senator Jeanne Shaheen (D-NH) participated in a virtual briefing with Lonza, a Portsmouth-based pharmaceutical company, on the firm's efforts to manufacture Moderna's mRNA-1273 COVID-19 vaccine candidate. The vaccine is nearing approval from the Food and Drug Administration, following the release of studies highlighting its efficacy in protect . . .
Today, U.S. Senator Jeanne Shaheen (D-NH) participated in a virtual briefing with Lonza, a Portsmouth-based pharmaceutical company, on the firm's efforts to manufacture Moderna's mRNA-1273 COVID-19 vaccine candidate. The vaccine is nearing approval from the Food and Drug Administration, following the release of studies highlighting its efficacy in protect . . .